Reliance Life Sciences Private Limited
4
Recalls
0
Units Recalled
0
Injuries
0
Deaths
Categories: Drug
2026-07-15 to 2026-07-15
| Date | Source | Product | Brand | Severity | Units |
|---|---|---|---|---|---|
| 2026-07-15 | FDA Drug | FDA Recall: Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, | Reliance Life Sciences Private Limited | Class II | N/A |
| 2026-07-15 | FDA Drug | FDA Recall: Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use | Reliance Life Sciences Private Limited | Class II | N/A |
| 2026-07-15 | FDA Drug | FDA Recall: Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, | Reliance Life Sciences Private Limited | Class II | N/A |
| 2026-07-15 | FDA Drug | FDA Recall: Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Int | Reliance Life Sciences Private Limited | Class II | N/A |